Senti Biosciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $5,856 | $0 | $0 | $333 |
Gross Profit | 2,928 | -1,467 | -1,461 | |
EBITDA | -5,001 | -13,438 | -11,889 | -14,840 |
EBIT | -609 | -14,902 | -13,356 | -16,301 |
Net Income | -610 | -28,866 | -11,203 | -12,111 |
Net Change In Cash | 5,856 | 0 | 0 | 333 |
Free Cash Flow | -13,515 | -7,866 | -8,345 | -11,697 |
Cash | 48,277 | 10,479 | 15,860 | 23,723 |
Basic Shares | 4,595 | 4,577 | 4,572 | 4,570 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $2,561 | $4,286 | $2,291 |
Gross Profit | -2,683 | 4,286 | -719 | |
EBITDA | -61,039 | -61,336 | -66,709 | -39,677 |
EBIT | -66,765 | -70,629 | -42,687 | |
Net Income | -52,790 | -92,919 | -45,791 | -55,319 |
Net Change In Cash | 0 | 2,561 | 4,286 | 2,291 |
Cost of Revenue | 1,696 | |||
Free Cash Flow | -41,423 | -64,433 | -76,270 | -40,178 |
Cash | 48,277 | 35,926 | 57,621 | 56,034 |
Basic Shares | 4,595 | 4,437 | 4,394 | 4,365 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.67 |
2024-09-30 | -$6.30 |
2024-06-30 | -$2.45 |
2024-03-31 | -$0.26 |
